Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Back to alerts
FORTISNSEFortis Healthcare Limited· Healthcare ServicesHighNeutral
Announced Tue, 11 Nov, 2025 · 22:36 IST

Fortis Healthcare Q2 FY26 Results: PAT jumps 70.3% YoY

Pat Growth 25pctEbitda Margin ExpansionExceptional ItemResults View source PDFExplain this filing

FORTIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.6%Reaction day
₹983.90
prior close
₹1004.10
announcement price
After-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.8%-2.4% vs market
Hospital peers, median of 18sector+0.3%-1.9% vs sector

On the reaction day the stock moved 2.4 pts less than Nifty Midcap 150 and 1.9 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.1
10m
-2.3
15m
-3.4
30m
-3.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.6+0.8-2.4+0.3-1.9
Next day
-3.2+0.4-3.7+0.2-3.4
2d
-4.7+0.5-5.2+0.1-4.8
3d
-3.8+1.2-5.0+0.7-4.5
4d
-5.7+0.5-6.2+0.1-5.8
5d
-6.1+0.9-6.9+0.5-6.6
1w
-6.2-0.3-5.9-0.3-5.9
15d
-8.9-0.4-8.4-3.1-5.7
1m
-11.1-0.3-10.8-1.6-9.5
2m
-9.2-1.2-8.0-6.5-2.7
3m
-5.5+0.1-5.6-8.4+2.9
UpDownMarket · Nifty Midcap 150Sector · Hospital peers, median of 18Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated revenue rose 17.3% YoY to INR 2,331 Cr. Operating EBITDA margin expanded to 23.9% from 21.9%. PAT grew 70.3% YoY to INR 329 Cr, including an exceptional gain of INR 23.5 Cr. Hospital business revenue up 19.3% to INR 1,974 Cr. Diagnostics revenue grew 7.3% with margin at 26.1%. Net debt rose to INR 2,219 Cr due to Agilus stake and Shrimann Hospital acquisitions.

Likely market impact

Strong quarter with robust profit growth and margin expansion. Higher debt from acquisitions, but leverage stays comfortable at 0.96x net debt to EBITDA.